References
- Choi WY, Nam HW, Kwak NH, Huh W, Kim YR, Kang MW, Cho SY, Dubey JP. Foodborne outbreaks of human toxoplasmosis. J Infect Dis 1997; 175: 1280-1282 https://doi.org/10.1086/593702
- Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197: 157-168 https://doi.org/10.1002/jcp.10364
- Denker EY. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 2003; 39: 193-203 https://doi.org/10.1016/S0928-8244(03)00279-7
-
Gazzinelli RT, Hieny S, Wynn T, Wolf S, Sher A. IL-12 is required for the T-cell independent induction of IFN-
$\gamma$ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993; 90: 6115-6119 https://doi.org/10.1073/pnas.90.13.6115 -
Bliss SK, Marshall AJ, Zhang Y, Denkers EY. Human polymorphonuclear leukocytes produce IL-12, TNF-
$\alpha$ , and the chemokines macrophage-inflammatory protein-1$\alpha$ and 1$\beta$ in response to Toxoplasma gondii antigens. J Immunol 1999; 162: 7369-7375 - Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, Hissong BD, Nguyen BV, Gadina M, Sher A, Paul WE, O'Shea JJ. Tbet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA 2001; 98: 15137-15142 https://doi.org/10.1073/pnas.261570598
-
Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, Woude GF, Sher A, Taylor GA. Inactivation of LRG-47 and IRG-47 reveals a family of interferon-
$\gamma$ -inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med 2001; 194: 181-187 https://doi.org/10.1084/jem.194.2.181 - Collazo CM, Yap GS, Hieny S, Caspar P, Feng CG, Taylor GA, Sher A. The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is STAT1 dependent and requires expression in both hematopoietic and non-hematopoietic cellular compartments. Infect Immun 2002; 70: 6933-6939 https://doi.org/10.1128/IAI.70.12.6933-6939.2002
-
Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY. Cutting edge: IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-
$\alpha$ in host macrophages. J Immunol 2005; 174: 3148-3152 - Sohn WM, Nam HW. Western blot analysis of stray cat sera against Toxoplasma gondii and the diagnostic availability of monoclonal antibodies in sandwich-ELISA. Korean J Parasitol 1999; 37: 249-256 https://doi.org/10.3347/kjp.1999.37.4.249
- Hoeck J, Woisetschlager M. Activation of Eotaxin-3/CCL26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 2001; 167: 3216-3222
- Ahn HJ, Song KJ, Son ES, Shin JC, Nam HW. Protease activity and host cell binding of the 42-kDa rhoptry protein from Toxoplasma gondii after secretion. Biochem Biophys Res Commun 2001; 287: 630-635 https://doi.org/10.1006/bbrc.2001.5637
- Kozma N, Halasz M, Polgar B, Poehlmann TG, Markert UR, Palkovics T, Keszei M, Par M, Kiss K, Szeberenyi J, Grama L, Szekeres-Bartho J. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006; 176: 819-826
- Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol 2005; 42: 295-303 https://doi.org/10.1016/j.molimm.2004.09.004
- Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Gouvello S, Gaulard P, Leroy K, Castellano F. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 2004; 104: 543-549 https://doi.org/10.1182/blood-2003-10-3545
- Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun 1996; 64: 897-904
- Alexander J, Jebbari H, Bluethmann H, Brombacher F, Roberts CW. The role of IL-4 in adult acquired and congenital toxoplasmosis. Int J Parasitol 1998; 28: 113-120 https://doi.org/10.1016/S0020-7519(97)00168-9
- Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 2001; 166: 2173-2177 https://doi.org/10.4049/jimmunol.166.4.2173
- MacMicking JD. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 2004; 25: 601-609 https://doi.org/10.1016/j.it.2004.08.010
- Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. Plos Pathogens 2005; 1: 187-201 https://doi.org/10.1371/journal.ppat.0010024
- Luder CG, Algner M, Lang C, Bleicher N, Gross U. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Int J Parasitol 2003; 33: 833-844 https://doi.org/10.1016/S0020-7519(03)00092-4
-
Chaves AC, Ceravolo IP, Gomes JA, Zani CL, Romanha AJ, Gazzinelli RT. IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-
$\gamma$ . Eur J Immunol 2001; 31: 333-344 https://doi.org/10.1002/1521-4141(200102)31:2<333::AID-IMMU333>3.0.CO;2-X - Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 2002; 70: 859-868 https://doi.org/10.1128/IAI.70.2.859-868.2002
-
Heller NM, Matsukura S, Georas SN, Boothby MR, Rothman PB, Stellato C, Schleimer RP. Interferon-
$\gamma$ inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 573-582 https://doi.org/10.1165/rcmb.2004-0195OC -
Huang Z, Xin J, Coleman J, Huang H. IFN-
$\gamma$ suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. J Immunol 2005; 174: 1332-1337 -
Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoiyes inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF
$\kappa$ B. J Immunol 2001; 167: 2193-2201 - Luder CG, Lang C, Giraldo-Velasquez M, Algner M, Gerdes J, Gross U. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II tranactivator CIITA. J Neuroimmunol 2003; 134: 12-24 https://doi.org/10.1016/S0165-5728(02)00320-X
- Goebel S, Gross U, Luder CG. Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alteration of poly(ADP-ribose) polymerase expression. J Cell Sci 2001; 114: 3495-3505
- Wurster AL, Whiters DJ, Uchida T, White MF, Grusby MJ. Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensible for IL-4-dependent rescue from apoptosis. Mol Cell Biol 2002; 22: 117-126 https://doi.org/10.1128/MCB.22.1.117-126.2002
- Fijutsu Y, Fukuda K, Kimura K, Seki K, Kumagai N, Nishida T. Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13. Invest Ophthalmol Visual Sci 2005; 46: 797-802 https://doi.org/10.1167/iovs.04-1016
- Schindler CW. JAK-STAT signaling in human disease. J Clin Invest 2002; 109: 1133-1137 https://doi.org/10.1172/JCI0215644
- Yang J, Aittomaki S, Pesu M, Carter K, Saarinen J, Kalkkinen N, Kieff E, Silvennoinen O. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J 2002; 21: 4950-4958 https://doi.org/10.1093/emboj/cdf463
- Valineva T, Yang J, Palovuori R, Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J Biol Chem 2005; 280: 14989-14996 https://doi.org/10.1074/jbc.M410465200
- Travagli J, Letourneur M, Bertoglio J, Pierre J. STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J Biol Chem 2004; 279: 35183-35192 https://doi.org/10.1074/jbc.M403223200
- Lad SP, Fukuda EY, Li J, Maza LM, Li E. Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection. J Immunol 2005; 174: 7186-7193
Cited by
- Coactivator P100 Protein Enhances STAT6-Dependent Transcriptional Activation But Has No Effect on STAT1-Mediated Gene Transcription vol.293, pp.6, 2009, https://doi.org/10.1002/ar.21143
- Toxoplasma Rhoptry Protein 16 (ROP16) Subverts Host Function by Direct Tyrosine Phosphorylation of STAT6 vol.285, pp.37, 2009, https://doi.org/10.1074/jbc.m110.112359
- Deactivation of STAT6 through Serine 707 Phosphorylation by JNK vol.286, pp.5, 2009, https://doi.org/10.1074/jbc.m110.168435
- Chronic Toxoplasmosis Modulates the Induction of Contact Hypersensitivity by TNCB in Mouse Model vol.53, pp.6, 2015, https://doi.org/10.3347/kjp.2015.53.6.755
- Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii vol.54, pp.1, 2016, https://doi.org/10.3347/kjp.2016.54.1.31
- Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi’s Sarcoma-Associated Herpesvirus for Viral Latency vol.13, pp.1, 2009, https://doi.org/10.1371/journal.ppat.1006124
- SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice vol.8, pp.None, 2017, https://doi.org/10.3389/fmicb.2017.01733